SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2148337

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2148337

Gene Manufacturing Market, By Product Type, By Manufacturing Process, By Manufacturing Scale, By Application, By End User, By Geography

PUBLISHED:
PAGES: 256 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Gene Manufacturing Market is estimated to be valued at USD 9.18 Bn in 2026 and is expected to reach USD 26.25 Bn by 2033, growing at a compound annual growth rate (CAGR) of 16.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 9.18 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 16.20% 2033 Value Projection: USD 26.25 Bn

The global gene manufacturing market is a disruptive sector of the biotechnology and life sciences industry that encompasses the mass production of plasmid DNA, viral vectors, mRNA and other nucleic acid-based products. The manufacturing capabilities underpin the development of gene therapy, cell therapy, CAR-T treatments and next-generation vaccines, which in turn fuels demand for scalable, high-quality and regulatory compliant production systems.

The global gene manufacturing market is driven by increasing investments in gene-based therapeutic pipelines for rare genetic conditions, cancer, and infectious diseases, which in turn increases the demand for advanced manufacturing infrastructure. It brings together biopharmaceutical companies, CDMOs, academic institutions, and government agencies, with continuous advances in genomics and bioprocessing further strengthening the demand for efficient and commercially scalable gene manufacturing technologies.

Market Dynamics

The global gene manufacturing market is driven by the rising number of gene and cell therapies progressing through clinical and commercial development and the growing need for scalable manufacturing capacity. The growth of mRNA-based technologies, government funding, public-private partnerships and collaborations in the industry are also driving investment in advanced manufacturing infrastructure.

However, a number of constraints are present in the market, such as high capital expenditure for cGMP facilities, complexity of viral-vector production, yield and batch consistency challenges and evolving regulatory requirements. Nevertheless, significant opportunities exist within the increasing outsourcing of gene manufacturing to specialized CDMOs, especially for small biopharmaceutical companies looking for flexible and cost-efficient production capabilities. Manufacturing efficiency and scalability are being improved by bioprocess automation, single-use systems, and AI-enabled quality control, while expanding gene-therapy pipelines targeting neurological, cardiovascular, and inherited metabolic disorders are driving further demand for specialized manufacturing capacity.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global gene manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Lonza Group Ltd., Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Holdings Corporation, Catalent, Inc., Charles River Laboratories International, Inc., AGC Inc., WuXi AppTec Co., Ltd., Takara Bio Inc., and Oxford Biomedica plc
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global gene manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene manufacturing market

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2021 - 2033)
    • Gene Therapy Vectors
    • Plasmid DNA
    • Messenger RNA (mRNA)
    • Other Gene Manufacturing Products
  • Manufacturing Process Insights (Revenue, USD Bn, 2021 - 2033)
    • Upstream Processing
    • Downstream Processing
    • Fill-Finish and Formulation
  • Manufacturing Scale Insights (Revenue, USD Bn, 2021 - 2033)
    • Preclinical/Research Scale
    • Clinical Scale
    • Commercial Scale
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
    • Gene Therapy
    • Cell Therapy
    • Vaccines
    • Research and Other Applications
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
    • Pharmaceutical and Biotechnology Companies
    • Contract Development and Manufacturing Organizations (CDMOs)
    • Academic and Research Institutions
    • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Lonza Group Ltd.
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • FUJIFILM Holdings Corporation
    • Catalent, Inc.
    • Charles River Laboratories International, Inc.
    • AGC Inc.
    • WuXi AppTec Co., Ltd.
    • Takara Bio Inc.
    • Oxford Biomedica plc
Product Code: CMI10168

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Gene Manufacturing Market, By Product Type
    • Global Gene Manufacturing Market, By Manufacturing Process
    • Global Gene Manufacturing Market, By Manufacturing Scale
    • Global Gene Manufacturing Market, By Application
    • Global Gene Manufacturing Market, By End User
    • Global Gene Manufacturing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Type Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Industry Trends

4. Global Gene Manufacturing Market, By Product Type, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Gene Therapy Vectors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Plasmid DNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Messenger RNA (mRNA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Other Gene Manufacturing Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Gene Manufacturing Market, By Manufacturing Process, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Upstream Processing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Downstream Processing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Fill-Finish and Formulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Gene Manufacturing Market, By Manufacturing Scale, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Preclinical/Research Scale
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Clinical Scale
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Commercial Scale
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Gene Manufacturing Market, By Application, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Gene Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cell Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Research and Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Gene Manufacturing Market, By End User, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Contract Development and Manufacturing Organizations (CDMOs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Academic and Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

9. Global Gene Manufacturing Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Manufacturing Process, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Manufacturing Scale, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Manufacturing Process, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Manufacturing Scale, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Manufacturing Process, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Manufacturing Scale, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Manufacturing Process, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Manufacturing Scale, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Manufacturing Process, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Manufacturing Scale, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Manufacturing Process, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Manufacturing Scale, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Lonza Group Ltd.
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • FUJIFILM Holdings Corporation
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Catalent, Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Charles River Laboratories International, Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AGC Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • WuXi AppTec Co., Ltd.
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takara Bio Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Oxford Biomedica plc
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!